From Self-sufficiency
Jump to: navigation, search
Systematic (IUPAC) name
ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate
Clinical data
Routes of
Tablets, injection
Legal status
Legal status
Pharmacokinetic data
Protein binding > 95%
Metabolism Hepatic
CAS Number 144-14-9
ATC code N01AH05 (WHO)
PubChem CID 8944
DrugBank APRD00741
ChemSpider 8600
Chemical data
Formula C22H28N2O2
Molar mass 352.47 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Physical data
Melting point 83 °C (181 °F)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Anileridine (trade name: Leritine) is a new synthetic analgesic drug and is a member of the piperidine class of analgesic agents It differs from meperidine (Demerol) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increase its analgesic activity.

Anileridine is no longer manufactured in the US or Canada.[1]


As tablets or injection.[2]


Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.[3] It is mostly metabolized by the liver.


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

ru:Анилэридин sv:Anileridin
  1. "Discontinued Prescription Drug Products". Canadian Pharmacists' Association. Retrieved 28 July 2008. 
  2. "Pharmaceutical Information - LERITINE". RxMed. Retrieved 16 June 2010. 
  3. "Anileridine Consumer Information". MedicineNet. Retrieved 28 July 2008.